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Viral infection of the central nervous system can lead to disability and death. Yet the majority of viral infections with central
nervous system involvement resolve with only mild clinical manifestations, if any. This is generally attributed to efficient
elimination of the infection from the brain coverings, i.e. the meninges, ependyma and chorioplexus, which are the primary
targets of haematogeneous viral spread. How the immune system is able to purge these structures from viral infection with only
minimal detrimental effects is still poorly understood. In the present work we studied how an attenuated lymphocytic chor-
iomeningitis virus can be cleared from the central nervous system in the absence of overt disease. We show that elimination of
the virus from brain ependyma, but not from brain parenchyma, could be achieved by a T cell-dependent mechanism operating
independently of major histocompatibility class I antigens and perforin. Considering that cytotoxic T lymphocyte-mediated
cytotoxicity is a leading cause of viral immunopathology and tissue damage, our findings may explain why the most
common viral intruders of the central nervous system rarely represent a serious threat to our health.
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Abbreviations: LCMV = lymphocytic choriomeningitis virus; MHC = major histocompatibility complex; NP = nucleoprotein;
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Introduction
Viruses are the most common infectious intruders to the CNS and
remain a significant source of neurological morbidity and mortality
worldwide. The United States Centres for Disease Control and
Prevention estimate that 20 000 cases of clinically manifested
viral CNS infections occur in the United States each year. In addi-
tion, and vastly exceeding these numbers, many of the common
viral infections ‘silently’ (i.e. in the absence of clinical symptoms or
overt disease) involve the CNS, or exhibit mild manifestations that
do not require diagnostic or therapeutic intervention. Hence, they
are not included in the above statistics (Logan and MacMahon,
2008). Mumps in the pre-vaccine era is a classic example of a viral
infection frequently accompanied by meningitis. CNS involvement
occurred in an estimated 50% of all infected individuals but mostly
went unrecognized and resolved without complications or seque-
lae (Johnstone et al., 1972; Hviid et al., 2008). Similar frequencies
of CNS involvement were observed during acute but uncompli-
cated systemic infection with measles (Gibbs et al., 1959;
Hanninen et al., 1980). Clinically, investigation of the topic has
been hampered by the fact that it requires sampling of CSF, an
intervention difficult to justify given the mostly benign and spon-
taneous outcome. Hence, similarly frequent mild CNS involvement
as in measles and mumps is also suspected for other viruses such
as influenza virus (Fujimoto et al., 1998) or coxsackie B virus
(Rubin et al., 1958), which are nowadays more widespread.
However, laboratory confirmation is not available.
Viral infections of the CNS are classified pathologically into
those restricted to the parenchyma (encephalitis) and those that
predominantly affect the coverings of the CNS (i.e. meninges,
ependyma and chorioplexus), although some overlap of these
categories is frequently observed. The majority of viral CNS infec-
tions result from haematogeneous dissemination and are initially
confined to the CNS coverings (Fields et al., 2006). Often clinically
manifested as ‘aseptic meningitis’, this syndrome summarizes a
group of disorders with a typically mild and self-limiting course
of disease (Adair et al., 1953; Irani, 2008). It is generally assumed
that immunocompetent individuals eliminate these infections from
the CNS coverings before a substantial parenchymal infection can
be established, and thus before substantial damage occurs.
Furthermore, properties intrinsic to the virus (cellular tropism,
cytolytic potential) and host parameters such as age (e.g. neonatal
versus adult life, thereby affecting the level of immunological com-
petence) influence whether the virus remains restricted to the
brain coverings or whether it also affects the CNS parenchyma.
Numerous DNA and RNA viruses including enteroviruses, morbilli-
viruses, herpes viruses, lentiviruses, flaviviruses and arenaviruses
are able to spread into the brain coverings in humans (Lee and
Davies, 2007). How they gain access to the CNS has been studied
extensively, and much effort has been given to elucidating
virus-host interactions and immune defence in the brain parench-
yma (Griffin, 2003; Hausmann et al., 2005; McGavern, 2005;
Bergmann et al., 2006; Ercolini and Miller, 2006; Tishon et al.,
2006). However, less is known about how infected hosts silently
cleanse the CNS coverings from viral infection, and thus how they
prevent not only serious complications from meningitis, but also
viral spread into the parenchyma.
Lymphocytic choriomeningitis virus (LCMV) represents the pro-
totypic member of the arenavirus family and is widely used to
study the dichotomous role of the antiviral immune response in
host protection and pathogenesis (Zinkernagel and Doherty, 1974;
Ahmed and Gray, 1996; Oldstone, 2007). LCMV is a natural
mouse pathogen but it is also suspected to be an underestimated
cause of aseptic meningitis in humans (Meyer et al., 1960; Jahrling
and Peters, 1992). As in humans, LCMV has the capacity to infect
the brain coverings of mice, and from there it gradually spreads
into the parenchyma (Thomsen, 2009). Intracerebral inoculation of
adult mice with LCMV has been studied for decades to define the
mechanisms underlying viral pathogenesis and immunopathology
in the CNS. After intracerebral administration most of the inocu-
lum is drained into the systemic circulation (Mims, 1960), initiating
a vigorous immune response. At the same time, the virus repli-
cates in the leptomeninges, choroid plexus and ependymal cells
(Lillie, 1945; Wilsnack and Rowe, 1964). LCMV is non-cytolytic in
mice, and hence the ensuing CNS disease is solely caused by the
immune response attacking the virus infection in the CNS.
Accordingly, T cell-depleted mice are resistant to LCMV-induced
fatal choriomeningitis (Cole et al., 1972). Histological examination
shows massive leucocyte infiltrates accumulating in the meningeal
and ventricular region of the brain 6–8 days after infection, con-
comitant with the onset of rapidly progressing convulsions and
death. In addition to these events in the brain coverings, T cell
infiltration has also been observed within the brain parenchyma,
and clinical disease has mostly been attributed to the latter part of
the inflammatory response (Christensen et al., 2004). CD8+ T cells
have long been identified as key players indispensable for disease
(Cole et al., 1972; Andersen et al., 1991). Yet recently the recruit-
ment of myelomonocytic cells was also found to be an important
step in pathogenesis (Kim et al., 2009), at least for the early man-
ifestation of the disease.
In contrast to the vast majority of humans with viral infection of
the CNS surface, intracerebral infection of mice with wild-type
LCMV strains is almost invariably lethal, even at the minimal infec-
tious dose (Bonilla et al., 2002). Thus, acute LCMV meningitis in
mice is only of limited use for investigating how a primary immune
response can purge viruses from the brain coverings without caus-
ing overt disease.
Therefore, using arenavirus reverse genetics, we recently gener-
ated an attenuated LCM virus exhibiting a fundamentally different
virus–host balance: recombinant LCMV expressing the surface gly-
coprotein of vesicular stomatitis virus (rLCMV/INDG) instead of
its own glycoprotein (Fig. 1A). Unlike wild-type LCMV such as
the Armstrong strain, rLCMV/INDG fails to cause disease
in intracerebral-infected adult mice (Pinschewer et al., 2003;
Bergthaler et al., 2006; Merkler et al., 2006). Nevertheless, it
establishes persistent infection in the CNS of immunodeficient
hosts (Merkler et al., 2006) owing to its non-cytolytic behaviour.
As an additional important difference to wild-type LCMV, rLCMV/
INDG replicates only in the CNS. Even in recombination-activating
gene (RAG)-deficient mice lacking T and B cells, interferon type I
prevents viral replication in other tissues (Merkler et al., 2006). In
several other model systems, viral elimination from the CNS can
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be affected by ongoing viral replication at additional sites, partic-
ularly when the virus overwhelms the host to cause immune
exhaustion (Wherry and Ahmed, 2004). Thus the rLCMV/INDG
model is well suited to study viral CNS clearance in mouse models
with defects in adaptive immunity.
In the present work we used this experimental model to dissect
the individual contribution of key components and pathways of the
adaptive immune response in purging a non-cytolytic virus infection
from the CNS in the absence of severe disease. Our results indicate
that viral elimination from ependymal cells can be achieved in a
T cell-dependent manner that occurs independently of major histo-
compatibility complex (MHC) class I and perforin, whereas the cyto-
lytic mechanisms of cytotoxic T cells become essential once the
virus has gained access to the parenchyma, notably to glial cells.
Figure 1 Genome organization, viral spread and blood brain barrier integrity following intracerebral infection with either LCMV Armstrong
or rLCMV/INDG. (A) Schema of the LCMV-Armstrong (LMCV-ARM) and rLCMV/INDG genomes. Both viruses consist of two
single-stranded negative-strand RNA segments, encoding two viral genes in ambisense orientation each. The long (L) segment encodes for
the RNA-dependent RNA polymerase L and for the matrix protein Z, while the short (S) segment carries theGP andNP genes. rLCMV/INDG
was created by substituting the LCMV-GP gene for vesicular stomatitis virus-INDG (Pinschewer et al., 2003). (B–E) C57BL/6 mice were
infected intracerebrally with rLCMV/INDG or LCMV-ARM as indicated or were left uninfected. (B and C) Viral S-segment (S seg.) RNA in
brain was detected at the indicated day (d) after intracerebral infection by northern blot (ethidium bromide staining of 28S rRNA indicates
loading control; lanes represent individual animals). (D) Immunohistochemical detection of LCMV-NP confirms reduced spread of rLCMV/
INDG as compared to LCMV-Armstrong. Note that LCMV- Armstrong (Days 4 and 6) and also rLCMV/INDG (Day 6) spreads into some
subependymal cells (arrows). (E) At Day 6 after infection, animals were given horseradish peroxide (HRP) intravenously. One hour later, they
were sacrificed for detection of horseradish peroxidase leakage into the brain parenchyma, indicative of blood brain barrier breakdown.
Representative pictures of horseradish peroxidase reactions are shown (n= 3–4 animals per group). Scale bar for D: 100 mm; for E: 500 mm.
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Materials and methods
Mice
C57BL/6 wild-type mice, recombination activation gene 2 deficient
mice (RAG/(Chen et al., 1993a)), B cell deficient mice (JHT/
(Chen et al., 1993b)), T cell deficient mice (TCRb/ (Mombaerts
et al., 1994)), major histocompatibility complex (MHC) class
I-deficient (b2m/ (Koller et al., 1990) and KbDb/ (Perarnau
et al., 1999)), major histocompatibility complex class II deficient
mice MHCII/ (Kontgen et al., 1993), perforin deficient mice PKO
(Kagi et al., 1994), TNF receptor double deficient mice (TNFR1/2/
(Peschon et al., 1998)), FAS deficient mice (FAS/ (Adachi et al.,
1995)), CD8 deficient mice (CD8/ (Fung-Leung et al., 1991)) and
interferon gamma deficient (GKO (Dalton et al., 1993)) mice (on
C57BL/6 background) as well as 129Sv/Ev wild-type mice and inter-
feron gamma receptor deficient mice (IFNGR/ (Huang et al., 1993))
on a 129Sv/Ev background were bred at the Institute of Laboratory
Animal Science, University of Zurich and housed under specific patho-
gen-free conditions during all experiments. Animal experiments were
carried out at the University of Zurich with authorization by the can-
tonal veterinary office and in accordance with the Swiss law for animal
protection, and at the University of Go¨ttingen with the authorization
by the district government in Braunschweig, in accordance with the
German law for animal protection.
Viruses, virus titrations, inoculations
and determination of neutralizing
antibodies
Virus stocks were prepared, infectivity was quantified and vesicular
stomatitis virus neutralizing antibodies were determined as described
previously (Pinschewer et al., 2004). For intracerebral inoculations,
3103 plaque forming units of the Armstrong strain of LCMV or
rLCMV/INDG were administered in a volume of 30ml through the
vertex of the skull using a 27 gauge needle. For intravenous infection,
2104 plaque forming units of the Armstrong strain of LCMV in a
volume of 200ml were administered into the tail vein. Vesicular sto-
matitis virus-hyperimmune serum (Pinschewer et al., 2004) was
administered i.p.
Detection of viral RNA
Viral S segment (3.4 kb) was detected by northern hybridization as
described previously (Pinschewer et al., 2003). A quantitive TaqMan
reverse transcribed (RT)-PCR protocol targeting the LCMV-
nucleoprotein (NP) gene (to be described elsewhere) was used to
quantify rLCMV/INDG S segment copies in the brain of infected
mice. Arbitrary viral RNA units were determined in a multiplex assay
with a commercial kit for detection of the housekeeping gene GAPDH,
serving as internal reference (Applied Biosystems).
Cytotoxicity assays and enumeration
of epitope-specific CD8+ T cells
Specific cytotoxic T cell activity of splenocytes was assayed in a 51Cr
release assay and epitope-specific CD8+ T cells were enumerated using
MHC class I tetramers as described (Bergthaler et al., 2006).
Histopathology
CNS tissue was prepared in hepes-glutamic acid buffer-mediated
organic solvent protection effect (HOPE) fixative (DCS Innovative)
(Olert et al., 2001) and embedded in paraffin as described pre-
viously (Bergthaler et al., 2007). Mice were not perfused prior to
tissue collection and fixation since rLCMV/INDG does not replicate
outside the CNS, and blood contains neither free infectivity nor
circulating infected cells (Merkler et al., 2006). Upon inactivation
of endogenous peroxidases (phosphate buffered saline/0.3% hydro-
gen peroxide, 30 min) and blocking (phosphate buffered saline/10%
foetal calf serum), sections were stained with primary antibodies:
mouse anti-neuronal nuclei NeuN (Chemicon International), mouse
anti-glial fibrillary acidic protein (astrocytes; Dako), mouse
anti-NogoA [oligodendrocytes, mAb11c7 (Oertle et al., 2003),
kindly provided by M. E. Schwab, Brain Research Institute, Zurich],
rat anti-mouse CD8 (BD PharMingen), rabbit anti-ionized calcium
binding adaptor-1 (microglia/macrophages; Wako Pure Chemical
Industries Ltd.), rabbit anti-Factor VIII (von Willebrand Factor;
endothelia; Abcam) and rat anti-LCMV NP (VL-4, Battegay et al.,
1991). Bound primary antibodies were visualized either by an
avidin-biotin technique with 3,30-diaminobenzidine or alkaline phos-
phatase/anti-alkaline phosphatase as chromogens (haemalaun coun-
terstaining of nuclei) for light microscopy or with the appropriate
species-specific Cy3- or Cy2-conjugated secondary antibodies (all
from Jackson ImmunoResearch Laboratories Inc.) with 4’,6-diamidi-
no-2-phenylindole (Sigma-Aldrich) nuclei counterstaining for fluores-
cence microscopy. To assess cellular distribution of LCMV at least
130 LCMV-NP+ cells per staining and group (average 416123
cells) were evaluated at 400 magnification. Number of
LCMV-NP+ cells allocated to a given cellular subtypes were
expressed as percent of total allocated LCMV NP+ cells.
Assessment of blood brain barrier
breakdown
Damage to the blood brain barrier was visualized by intravenous injec-
tion of 400ml of 2% horseradish peroxidase (Sigma) dissolved
in phosphate-buffered saline (Claudio et al., 1990; Hawkins et al.,
1990). Horseradish peroxidase leakage into the brain parenchyma
was made evident in horseradish peroxidase reactions on 6 mm-thick
snap-frozen sections of brain tissue.
Statistical analysis
ANOVA with Bonferroni post test was used for the comparison of
individual values from multiple groups. Viral RNA units were
log-transformed for statistical analysis. Differences in individual
values between two groups were analysed by t-tests (unpaired,
two-tailed) and virus clearance was compared in log rank tests.
These analyses were performed using GraphPad Prism software ver-
sion 4.0b. Two-way ANOVA with Bonferroni’s post test for a com-
bined analysis of values from two groups in two independent
experiments was performed using SPSS version 13.0. P-values 50.05
were considered statistically significant () and P-values 50.01 were
considered highly significant (), whereas P-values 40.05 were con-
sidered statistically not significant.
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Results
Reduced spread of rLCMV/INDG in CNS
coverings correlates with a largely intact
blood brain barrier
We first infected mice intracerebrally with rLCMV/INDG or with
its wild-type counterpart LCMV Armstrong, and compared the
viral burden in CNS and its topographical distribution over time.
Northern blot analysis of LCMV Armstrong-infected brain tissue
detected similar amounts of viral RNA on Day 4 as on Day 6
when the animals displayed signs of terminal disease (Fig. 1B). In
addition, LCMV Armstrong RNA was also detectable in spleen
on Days 1 and 4 after infection (Supplementary Fig. S1). By the
same methods, rLCMV/INDG RNA became detectable no earlier
than at Day 6, and was eliminated by Day 8 (Fig. 1B and C). In
agreement with our previous findings (Merkler et al., 2006),
rLCMV/INDG RNA could not be detected in spleen or liver at
any time point (Supplementary Fig. S1). Northern hybridization
had suggested lower levels of rLCMV/INDG than of Armstrong
in the CNS (Fig. 1B), which was confirmed by histological ana-
lysis (Fig. 1D). Both viruses were mostly restricted to the brain
coverings (i.e. leptomeninges, ependyma and chorioplexus).
However, rLCMV/INDG infected far fewer cells than
Armstrong, both on Day 4 and 6 after infection. rLCMV/INDG
was found in small foci and in isolated infected cells of lepto-
meninges and ependyma on Day 4, in somewhat larger patches
of infected cells of the same structures on Day 6 after infection,
and was cleared thereafter (Days 8 and 14, Fig. 1D). In contrast,
as early as on Day 4 Armstrong-infected cells formed a contin-
uous layer comprising meninges, ependymal cells and choroid
plexus. Furthermore, a small but consistent fraction of parench-
ymal cells in close proximity to the ventricular ependyma
(referred to as ‘subependymal cells’) were also infected, as pre-
viously reported (Christensen et al., 2004) (arrows in Fig. 1D).
We further analysed the integrity of the blood brain barrier at
Day 6 after infection with either LCMV Armstrong or rLCMV/
INDG. This time point was chosen for analysis since rLCMV/
INDG RNA levels and T cell infiltrates were highest (Fig. 1B
and text below) and also because of terminal disease in LCMV
Armstrong-infected animals (Fig. 1E). Extensive disruption of the
blood brain barrier was found in LCMV Armstrong infection,
which was evident in widespread leakage of intravenously
administered horseradish peroxidase into the brain parenchyma,
confirming earlier observations in LCMV-infected mice (Marker
et al., 1984; Andersen et al., 1991). In contrast, the blood brain
barrier was only very modestly affected in rLCMV/INDG-infected
animals. rLCMV/INDG is known to persist in the brain of immu-
nodeficient hosts, such as neonates, without causing disease
(Pinschewer et al., 2003; Bergthaler et al., 2006; Merkler
et al., 2006). Hence the present data indicate that adult infec-
tion of mice with rLCMV/INDG provides a useful model to
study basic mechanisms of silent immune-mediated viral clear-
ance from the brain coverings.
The benign course of intracerebral
rLCMV/INDG infection is not due
to an altered antiviral cytotoxic
T cell response
We had previously demonstrated that the failure of rLCMV/INDG
to elicit fatal choriomeningitis was not due to its lack of LCMV
glycoprotein (Fig. 1A) as an antigenic target of the cytotoxic T cell
response to LCMV Armstrong (Bergthaler et al., 2006). We had
also shown that intracerebral rLCMV/INDG infection induces cyto-
toxic T cell responses of high frequency and long-lived protective
capacity (Bergthaler et al., 2006). Yet LCMV Armstrong-induced
cytotoxic T cells reached even higher frequencies and exhibited far
higher cytotoxic activity in primary ex vivo cytotoxic T cell assays
(Pinschewer et al., 2004). This difference in cytotoxic T cell
response rather than the viral ability to spread in the CNS could
thus have accounted for the differential clinical outcome after
rLCMV/INDG and LCMV Armstrong infection. To address this
possibility, we infected mice simultaneously with rLCMV/INDG
and/or LCMV Armstrong using the intracerebral and intravenous
routes in various combinations (Fig. 2A). Besides recording the
clinical outcome (Fig. 2A), we used MHC class I tetramers to
Figure 2 Absence of disease after rLCMV/INDG intracerebral
infection is not due to altered antiviral cytotoxic T cell response.
(A) C57BL/6 mice were infected by the intravenous and
intracerebral route with LCMV-Armstrong (LCMV-ARM) and/or
rLCMV/INDG in various combinations as indicated in the chart,
summarizing also the clinical outcome of infection. Animals
exhibiting clinical signs of terminal choriomeningitis were
euthanized in accordance with the Swiss law for animal
protection. (B) NP396-specific (expressed by both viruses)
and GP33-specific (expressed by LCMV-ARM) CD8+ T cells
in blood were enumerated on Day 6 by MHC class I tetramer
staining. (C) Primary ex vivo cytotoxic T cell activity of
splenocytes against NP396 was tested 6 days after infection.
Symbols represent the mean SEM of three mice per group.
Symbol keys are provided in the table of panel A.
i.c. = intracerebral; i.v. = intravenous.
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monitor the magnitude of the antiviral cytotoxic T cell response
(Fig. 2B), and its cytolytic activity was determined in primary ex
vivo cytotoxic T cell assays (Fig. 2C). Co-infection with rLCMV/
INDG intracerebral and Armstrong intracerebral resulted in lethal
choriomeningitis analogous to Armstrong intracerebral single
infection. This excluded dominant negative immunomodulatory
effects of rLCMV/INDG on CNS immunopathogenesis. Further-
more we found that intracerebral administration of Armstrong
caused the same T cell response and disease regardless of whether
or not Armstrong was additionally administered intravenously.
Thus, we tested whether Armstrong intravenous infection could
drive a cytotoxic T cell response of optimal magnitude and cyto-
lytic capacity that would trigger CNS disease in animals simulta-
neously infected with intracerebral rLCMV/INDG. Although the
magnitude and functionality of the peripheral antiviral cytotoxic
T cell response was equivalent or even slightly higher than in
Armstrong single-infected mice, these animals failed to display
evidence of increased morbidity, both by clinical assessment and
also by testing blood brain barrier permeability analogous to the
experiments displayed in Fig. 1E (data not shown). Hence, these
results confirm that the ability of LCMV Armstrong but not
rLCMV/INDG to cause CNS disease is unrelated to differences in
the cytotoxic T cell response elicited, but rather reflect differential
viral load and/or distribution in CNS tissues.
T cells—but not antibodies—are
necessary to clear recombinant
LCMV/INDG from the CNS
Next we analysed the contribution of the adaptive cellular and
humoral immune response to silent rLCMV/INDG clearance from
the CNS. B cell-deficient JHT/ mice exhibited unimpaired virus
clearance whereas the brains of T cell-deficient TCRb/ mice
and RAG/ animals (lacking T as well as B cells) harboured con-
siderable levels of persisting virus as assessed on Day 14 of infec-
tion and thereafter (Fig. 3A and data not shown). The antiviral
CD8+ T cell response to the immunodominant epitope NP396 was
measured in peripheral blood on Day 8 using MHC class I tetra-
mers (Fig. 3B). These responses were similarly vigorous in mice
with a targeted deletion of the JH locus (JHT mice) lacking B
cells, and C57BL/6 control mice, but were absent in CD8+ T
cell-deficient TCRb/ and RAG/ mice, as expected, and there-
fore correlated with viral clearance. Notably, rLCMV/INDG intra-
cerebral infection also elicited a vigorous and early
virus-neutralizing antibody response (Fig. 3C and D). Its absence
in JHT mice did not change the clinically silent course of rLCMV/
INDG infection (not shown), indicating that silent clearance of
rLCMV/INDG but not LCMV Armstrong was unrelated to differ-
ences in the virus-neutralizing antibody responses elicited by the
two viruses. It also suggested that antibodies were not essential
for rLCMV/INDG clearance from the CNS, but a contributory role
in this process was not excluded. TCRb/ not only failed to
mount cytotoxic T cell responses but in addition they displayed
considerably reduced total virus-neutralizing antibody titres (IgM
plus IgG, P50.01) and a virtual absence of the
b-mercaptoethanol-resistant virus-neutralizing antibody fraction
(IgG, P50.01). This was presumably due to the lack of T cell
help for antibody production and immunoglobulin class switch,
and could also have contributed to defective viral clearance in
these animals. To address this possibility, we reconstituted
TCRb/ animals with specific antibodies by intraperitoneal
administration of hyperimmune serum (Fig. 3E–G). While neutra-
lizing IgG in serum was restored to virtually normal levels, viral
persistence remained unaffected. In summary, these findings indi-
cate that T cells play an essential role in the silent clearance of
rLCMV/INDG from the CNS, a process that largely occurs inde-
pendently of systemic antiviral antibodies.
Clearance of LCMV/INDG from the
CNS is dependent on MHC class I
and perforin
Considering the key role of T cells in the clearance process, we
dissected the contribution of MHC class I- (MHCI-) and class II-
(MHCII-) restricted responses in rLCMV/INDG clearance from the
brain. Three of four MHC class I-deficient (MHCI/) mice exhib-
ited rLCMV/INDG RNA on Day 14 after infection whereas in mice
lacking MHC class II (MHCII/) virus was undetectable (Fig. 4A).
The differential ability to eliminate rLCMV/INDG from the CNS
correlated with the normal generation of virus-specific CD8+ T
cells in MHCII/ mice, whereas MHCI/ mice are devoid of a
CD8+ T cell compartment (Fig. 4B). Unlike in the experiment
depicted in Fig. 4A, a repeat experiment in MHCI/ mice resulted
in invariable viral persistence. Altogether, rLCMV/INDG persisted
in six out of seven MHCI/ mice tested, which was significantly
different from the uniform clearance in C57BL/6 wild-type con-
trols (P50.01). To corroborate these findings in an independent
knockout mouse model, we assessed rLCMV/INDG clearance from
the CNS of CD8/ mice, which also lack MHCI-restricted T cells.
Virus persisted in the brains of all four CD8/ infected mice,
further supporting a key role of MHCI-restricted T cell responses
in rLCMV/INDG clearance from the CNS (Fig. 4C and D,
P50.0001 for a combined analysis of virus clearance in C57BL/
6 versus CD8+ T cell-deficient MHCI/ and CD8/ mice). As a
next step we analysed the individual contribution of Fas, perforin,
interferon- and tumour necrosis factor- for eliminating rLCMV/
INDG (Figs 4E–H and Supplementary Fig. S2). Unimpaired virus
control in mice lacking either tumour necrosis factor receptors
1 and 2 (TNFR1/2/), FAS (FAS/), interferon- (GKO) or inter-
feron- receptor contrasted with clearly detectable viral persis-
tence in the brain of six out of eight perforin-deficient mice
tested in two independent experiments (Fig. 4E and H; data not
shown; P50.01 for virus clearance in perforin-deficient mice
versus C57BL/6 control mice). Impaired clearance of virus from
the CNS of perforin-deficient mice was accompanied by normal
frequencies of viral epitope-specific CD8+ T cells in peripheral
blood (P= 0.69 for NP396-specific CD8+ T cell frequencies in
perforin-deficient mice versus C57BL/6 mice; combined analysis
of Figs 4F and I), as expected (Badovinac et al., 2002). This indi-
cated that it was indeed the absence of perforin-dependent cyto-
lytic pathways rather than a general impairment of CD8+ T cell
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responses that caused viral persistence in the CNS of
perforin-deficient mice.
To gain further insights on how rLCMV/INDG persisted in the
CNS of perforin-deficient, TCRb/ and RAG/ mice but not in
C57BL/6 controls, we performed histological time course analyses
of viral antigen and of infiltrating CD8+ T cells. Four days after
infection the virus was restricted to ependymal cells from where it
spread into a few subependymal cells by Day 6 (Fig. 5A). These
early events were identical in T cell-competent perforin-deficient
and wild-type animals as well as in T cell-deficient TCRb/ and
RAG/ mice. However, C57BL/6 wild-type animals eliminated
the virus by Day 8, whereas slowly but steadily increasing numbers
of infected cells were found within the CNS parenchyma of
perforin-deficient, TCRb/ and RAG/ mice on Days 8, 10
Figure 3 T cells—but not antibodies—are necessary for clearance of rLCMV/INDG from the CNS. Mice of the indicated genotypes were
infected with rLCMV/INDG intracerebrally. (A) Detection of viral S-segment (S seg.) RNA in the brain by northern blot on Day 14
(ethidium bromide staining of 28S rRNA indicates loading control). (B) Frequencies of NP396-specific CD8+ T cells in blood were
determined on Day 8 using MHC class I tetramers. TCRb/ and RAG/ mice lack CD8+ T cells. (C and D) Virus-neutralizing total Ig (C)
and IgG (D) were determined at the indicated time points. (E–G) C57BL/6, JHT and TCRb/ mice were infected as above. An additional
group of TCRb/ mice was treated with 500 ml of vesicular stomatitis virus-immune serum on Day 7. (E) Viral RNA in the brain was
detected on Day 14 by northern hybridization. (F and G) Virus neutralizing total Ig and IgG titres in serum were determined over time.
Lanes in A and E and symbols in B–D represent individual mice. Symbols in F–G represent the mean SEM of three mice per group.
Representative results from two similar experiments are shown. n.d. = not detectable; n.s. = not significant (P40.05); ** = highly
significant (P50.01).
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and 12. Comparable virus dissemination in these three knockout
strains of mice supported the notion that perforin- and
MHCI-dependent T cell control was primarily responsible for pre-
venting persistence of rLCMV/INDG in the brain parenchyma. The
failure of perforin-deficient mice to clear rLCMV/INDG was not
due to a potential delay or impairment of CD8+ T cell trafficking to
infected brain regions (Fig. 5B). In C57BL/6 mice, as in
perforin-deficient mice, infiltrating CD8+ T cells were first detected
on Day 6 in similar numbers. Unlike in wild-type controls, where
cytotoxic T cell infiltration in the meninges and periventricular
areas peaked at this time point and declined thereafter, cytotoxic
T cell infiltrates in perforin-deficient mice increased even further at
Days 8, 10 and 12, presumably as a result of persisting viral anti-
gen. In summary, these data show that MHCI-restricted
perforin-dependent mechanisms play a key role in the silent
clearance of rLCMV/INDG from the CNS.
Virus clearance from parenchyma—but
not from ependyma—depends on MHC
class I and perforin
The above analyses demonstrated similar dissemination of rLCMV/
INDG in the parenchyma of perforin-deficient, TCRb/ and
RAG/ mice. However, differential infection rates were noted
in the ependyma of the different mouse strains (Fig. 5, insets in
Day 12 images). Thus we studied the cell types in which rLCMV/
INDG persisted when infected mice lacked either T or B cells
Figure 4 Clearance of LCMV/INDG from the CNS is dependent on MHC class I and perforin. Mice of the indicated genotypes were
infected with rLCMV/INDG intracerebrally. (A, C, E, G and H) Viral S-segment (S seg.) RNA was detected by northern blot on Day 14 after
intracerebral infection. Ethidium bromide staining is shown as loading control. (B, D, F and I) NP396-specific CD8+ T cell frequencies in
blood were enumerated at Day 7 after infection. MHCI/ mice and CD8/ mice lack CD8+ T cells. Symbols and lanes represent
individual mice. In figure F and I, multiple comparisons were not performed since the F-test of ANOVA failed to detect significant
differences (P40.05). n.d. = not detectable; n.s. = not significant (P40.05).
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(RAG/), the entire T cell compartment (TCRb/),
MHCI-restricted T cells (MHCI/) or perforin as a key component
of cytolytic CD8+ T cell activity. Immunohistochemical co-stains
were performed 2 weeks after rLCMV/INDG infection using a
LCMV NP-specific antibody in combination with cell type-specific
markers (Fig. 6). Striking differences were noted in the ependyma
on Day 14, and were further supported by the kinetic analysis of
virus distribution depicted in Fig. 5. Unlike in the early phase of
infection when the virus was mostly confined to the brain cover-
ings (compare Figs 1D and 5), MHCI/ and perforin-deficient
animals displayed very few infected ependymal cells (MHCI/
5%, perforin-deficient 2%). In contrast, ependymal cells were
the most frequently infected cell type (47%) in TCRb/ mice
and RAG-/- mice (48%). Within the parenchyma, a similar global
picture was found in all four knockout mouse strains, with the
majority of infected cells identified as astrocytes that were predo-
minantly located in periventricular areas (67% of infected cells
positive for glial fibrillary acidic protein in MHCI/ mice; 60%
in perforin-deficient, 31% in TCRb/, 29% in RAG/ mice).
To a lesser degree, viral infection co-localized with the oligodendro-
cyte marker NogoA (MHCI/ 14%, perforin-deficient 24%,
TCRb/ 8%, 14% in RAG/ mice), with the neuronal marker
Figure 5 rLCMV/INDG dissemination in the brain of perforin-deficient, TCRb/ and RAG/ mice, and dense CD8+ T cell infiltrates in
perforin-deficient mice. Perforin-deficient (PKO), TCRb/, RAG/ and C57BL/6 wild-type control mice were infected with rLCMV/
INDG intracerebrally and were sacrificed at the indicated time points. Brain tissues were processed for immunohistochemical analysis of
LCMV NP (A) and CD8+ T cells (B). The latter analysis was only performed for perforin-deficient and C57BL/6 mice since TCRb/- and
RAG/ mice lack T cells. Representative images of 2–4 animals per group and timepoint are shown. Arrowheads in (A) indicate infected
(LCMV NP-positive) subependymal cells. Insets in the Day 12 timepoints of (A) show persisting infection of ependymal cells in TCRb/
and RAG/ but not in perforin-deficient mice, whereas subependymal cells are infected in all three knockout strains. Scale bars
A: 100mm; B: 50 mm. d = days post intracerebral infection.
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NeuN (MHCI/ 3%, perforin-deficient 4%, TCRb/ 11%, 6% in
RAG/ mice) and with the microglia/macrophage marker ionized
calcium binding adaptor-1 (MHCI/ 11%, perforin-deficient 10%,
TCRb/ 3%, 3% in RAG/ mice). Infection of endothelial cells
was not detected, even when assessed in RAG/ mice
(Supplementary Fig. S3), and endothelia were therefore not
included in the above analyses. Taken together, these findings sug-
gest that, unlike in the parenchyma where the cell type-specific
distribution of virus is similar in all four genotypes of knockout
mice tested, silent clearance from ependyma could occur in a
MHCI- and perforin-independent yet T cell-dependent fashion.
Total viral RNA loads in the brain of perforin-deficient, MHCI/,
TCRb/ and RAG/ mice are similar as determined by quantita-
tive RT-PCR (Fig. 6C), providing evidence that within the brain
parenchyma, adaptive immune pathways other than MHCI- and
perforin-dependent T cell clearance do not substantially influence
rLCMV/INDG persistence. At the same time, these RT-PCR data
suggest that viral RNA in the ependyma does not represent
a major fraction of the total viral RNA accumulating in the
CNS of TCRb/ and RAG/ mice. This may suggest that
ependymal cells are less permissive to viral RNA amplification than
the parenchyma.
Discussion
In contrast to viral encephalitis (i.e. infection of the brain parench-
yma), viral infections generally follow a benign course if predomi-
nantly confined to the brain coverings. The underlying reasons are
still poorly understood. In the current study we used a panel of
gene-targeted mice to study redundant and non-redundant arms
of adaptive immunity in viral clearance from CNS coverings versus
Figure 6 The cell type-specific distribution of rLCMV/INDG in the CNS is different in TCRb/ and RAG/ mice as compared to
perforin-deficient and MHCI/ mice. Mice of the indicated genotypes were infected with rLCMV/INDG intracerebrally. Fourteen days
later they were sacrificed and brain tissues were processed for histological analysis of LCMV NP. (A) Ependyma was differentiated based
on morphological criteria (arrows in top panel) combined with immunohistochemical detection of LCMV NP (brown). Infection of
parenychmal cell types (bottom panels) was detected by combining LCMV NP staining (red) with cell type-specific markers (green)
in immunofluorescent co-staining as indicated. Arrowheads point out colocalization of cell type-specific markers with LCMV NP in
immunofluorescence images. Representative images from three to four animals per group are shown. Scale bar: 50 mm. (B) Histological
images were quantified to define the proportion of each cell type within the total population of infected cells. (C) Viral RNA loads in the
brain of the indicated mouse strains were measured by quantitative RT-PCR and are displayed in arbitrary units (see ‘Materials and
methods’ section). Bars represent the mean + SD of four to seven animals per group. Viral RNA loads in infected C57BL/6 mice were
significantly different from perforin-deficient (PKO), MHCI/, TCRb/ and RAG/ mice (P50.01), whereas the latter four were
not significantly different from each other (P40.05 for all comparisons). The technical background was determined in brain tissue
of uninfected mice (mean of six animals indicated as dashed line), and was not significantly different from infected C57BL/6 wild-type
mice (P40.05, not shown).
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parenchyma. The differences discovered here offer a possible
explanation for the fundamentally different clinical manifestations
of viral infection in these two CNS compartments.
Based on the present results and on earlier data, we suggest the
following scenario for viral clearance in our model of ‘aseptic men-
ingitis’. Blood-borne virus initially spreads to the CNS coverings.
Both LCMV Armstrong and rLCMV/INDG (albeit the latter to a
lesser extent) will slowly but steadily invade the brain parenchyma,
spreading from cell to cell. With the onset of the adaptive
immune response, ependymal viral replication is cleared in a
T cell-dependent manner but independently of MHCI and per-
forin, a non-cytolytic process causing only minimal clinical mani-
festations, if any. Astrocytes contribute to the formation of the
blood brain barrier and are close to the CNS coverings, rendering
them a first viral target in the parenchyma. This most likely
explains the high rate of astrocyte infection in MHCI/, PKO,
TCRb/ and RAG/ mice on Day 14 after infection (compare
Fig. 6), an assumption that is supported by the finding that neu-
ronal infection becomes more prominent with time (data not
shown). A reductionist model suggests that the ensuing cytotoxic
T cell response eliminates the infected astrocytes by
MHCI-dependent, perforin-mediated cytotoxicity. Unlike clearance
from the CNS coverings, this cytolytic process inflicts damage to
the blood brain barrier (compare Fig. 1E) and, together with other
factors such as the local inflammatory tissue response, will lead to
breakdown of the blood brain barrier. It seems likely that, depend-
ing on the number of infected astrocytes in the blood brain barrier
(i.e. virus load; high in LCMV Armstrong, low in rLCMV/INDG
infection), the resulting damage to the blood brain barrier will
vary, and thus also the extent of serum protein leakage into the
parenchyma. Once a certain level is reached, increased intracranial
pressure will lead to the classical clinical signs of meningitis
including nausea, seizures and ultimately death (Doherty and
Zinkernagel, 1974; Camenga et al., 1977; Andersen et al.,
1991). In agreement with this scenario, Christensen and col-
leagues (2004) found that delayed recruitment and accumulation
of cytotoxic T cells in the brain parenchyma caused a delay in the
onset of disease in LCMV-infected CXCL10- or CXCR3-deficient
mice, despite normal inflammatory cell recruitment to the brain
coverings (Christensen et al., 2004).
The precise molecular mechanisms as to how T cells effect
non-cytolytic clearance of the brain coverings remains to be
addressed in future work. Its occurrence independent of MHCI
suggests that MHCII-restricted T cell responses or non-classical T
cells and their respective effector molecules may be involved.
Myelomonocytic cells have recently been identified as previously
neglected players in LCMV-host interactions within the CNS, and
aside from T cells, monocyte/macrophages were also found to
accumulate in the CNS coverings during rLCMV/INDG clearance
(data not shown). Their presence could be a simple consequence
of inflammation but they may also contribute to clearance in a
direct or indirect manner. The study of their contribution to viral
clearance is complicated by considerable redundancy with other
pathways, stepping in when myelomonocytic inflammatory cells
are experimentally depleted (Kim et al., 2009). For similar reasons,
it may be difficult to delineate the precise role of T cell effector
pathways other than perforin that may contribute to clearance
of rLCMV/INDG from the CNS parenchyma (Griffin, 2003).
However, the contribution of these pathways, unlike that of per-
forin, may simply have remained undetected owing to a higher
degree of redundancy.
The model of adult intracerebral infection with rLCMV/INDG
offers several features that render it particularly amenable to the
investigation of viral clearance in aseptic meningitis. The virus’
non-cytolytic behaviour avoids complications related to viral
spread in immunocompromised animals, and as reported here,
its attenuation avoids the fatal immunopathological complications
of wild-type LCMV infection (Cole and Nathanson, 1974). On the
flip-side of the coin, cytopathic effects of viral infection may also
contribute to the clinical picture of ‘aseptic meningitis’ and are not
part of the model. Nonetheless, rLCMV/INDG infection is ideally
suited for the investigation of silent clearance, the most frequent
yet often neglected outcome of viral CNS infection.
The present data delineate a clear dichotomy in the mechanisms
underlying virus clearance from CNS coverings and parenchyma.
MHCI- and perforin-dependence of the latter, but not the former,
provides one likely explanation for the most frequently self-limiting
course of viral CNS infection.
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